| Ytd | -67.04% | |
| 1y | -76.34% |
| Open | 0.37 | Prev Close | 0.38 | Low | 0.37 | High | 0.41 | Mkt Cap | 9.82M |
| Vol | 285.69K | Avg Vol | 10.62M | EPS | -1.06 | P/E | N/A | Forward P/E | -0.90 |
| Beta | 62.82 | Short Ratio | 1.95 | Inst. Own | 13.74% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 0.30 | 200-d Avg | 0.80 | 1yr Est | 13.00 |
BioRestorative Therapies, Inc. ("BioRestorative," "BRTX," or the "Company")
MELVILLE, N.Y., June 25, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative,”